Nuwiq Kit
Product Images NDC 68982-149

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Nuwiq (NDC 68982-149). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Octapharma Usa Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image File (Img0001)

A text panel presenting formulas related to dosing calculations for Factor VIII activity. It shows equations for calculating the required IU based on body weight, desired FVIII rise, and units per deciliter, as well as the expected FVIII rise from administered IU and body weight.*

FDA Label Image

Image File (Img0002)

An instructional diagram showing step-by-step preparation of NUWIQ Antihemophilic Factor (Recombinant) kit for intravenous use. Panels depict removing vial caps, attaching and using a syringe to withdraw solution, and mixing or transferring medication from vial to syringe, demonstrating proper handling and assembly technique.*

FDA Label Image

Image File (Img0003)

Instructional diagram showing step-by-step preparation and assembly of a syringe and vial for intravenous use. The panels illustrate removal of caps, opening vial seals, inserting a needle into the vial, mixing or drawing liquid, and securing syringe components consistent with drug kit preparation.*

FDA Label Image

Image Description (Img0004)

NUWIQ 250 IU Kit label for Antihemophilic Factor (Recombinant), a plasma derivative for intravenous use. The label states the product is solvent/detergent treated and nanofiltered, provided as lyophilized powder for injection after reconstitution, contains no preservative, and is Rx only. Manufactured by Octapharma USA Inc.*

FDA Label Image

Image Description (Img0005)

Packaging label for NUWIQ 250 IU Range Antihemophilic Factor (Recombinant) kit containing lyophilized powder and solvent for intravenous injection. Label indicates Rx only, includes storage instructions, package contents, and manufacturer details Octapharma AB, distributed by Octapharma USA Inc. The label also lists ingredients in the reconstituted solution and handling precautions.*

FDA Label Image

Image Description (Img0006)

Label of NUWIQ 500 IU Range kit containing Antihemophilic Factor (Recombinant) as a plasma derivative for intravenous injection. The label states it is solvent/detergent treated, nanofiltered, and lyophilized powder for injection after reconstitution with the supplied solvent. It is labeled Rx only and manufactured by Octapharma USA Inc., Octapharma AB, Sweden. The label includes U.S. License No. 1646 and lot number and expiration date fields.*

FDA Label Image

Image Description (Img0007)

NUWIQ 500 IU Range Antihemophilic Factor (Recombinant) kit packaging showing product name, strength, and dosage form as a lyophilized powder for intravenous use. The label includes components such as vial with lyophilized powder, pre-filled syringe with water, vial adapter, butterfly needle, and alcohol swabs. The labeler is Octapharma USA Inc.*

FDA Label Image

Image Description (Img0008)

NUWIQ 1000 IU Range Antihemophilic Factor (Recombinant) packaging label. The label indicates the product is a solvent/detergent treated, nanofiltered lyophilized powder for intravenous injection after reconstitution. It is prescribed for intravenous use only, contains no preservatives, and must not be frozen. Manufactured by Octapharma USA Inc.*

FDA Label Image

Image Description (Img0009)

NUWIQ 1000 IU Range Antihemophilic Factor (Recombinant) kit carton shows product name, dosage strength, and recombinant factor designation. The label states it is an intravenous plasma derivative by Octapharma USA Inc. Kit contents and storage instructions appear on panel, including vials, syringe, and components not made with natural rubber latex.*

FDA Label Image

Image Description (Img0010)

NUWIQ 1500 IU Range kit label showing Antihemophilic Factor (Recombinant), solvent/detergent treated and nanofiltered. This lyophilized powder for intravenous injection requires reconstitution with the supplied solvent. Manufactured by Octapharma AB, Sweden, with U.S. license number 1646. The label includes lot numbers and expiration dates.*

FDA Label Image

Image Description (Img0011)

NUWIQ 1500 IU Range antihemophilic factor (recombinant) intravenous kit packaging label by Octapharma USA Inc. The label displays the product name, strength, dosage form (kit), and contents including vial with lyophilized powder, pre-filled syringe with water for injection, vial adapter, needle, and swabs. Storage instructions indicate keeping at 2-8°C, not freezing, and use within 3 hours after reconstitution. Manufacturer Octapharma AB and distributor Octapharma USA are noted along with U.S. license information.*

FDA Label Image

Image Description (Img0012)

NUWIQ 2000 IU Range kit label featuring Antihemophilic Factor (Recombinant). It is a solvent/detergent treated, nanofiltered lyophilized powder for intravenous injection after reconstitution with supplied solvent. The label includes usage instructions, manufacturing information by Octapharma AB, Sweden, and dosing range indication.*

FDA Label Image

Image Description (Img0013)

NUWIQ 2000 IU Range Antihemophilic Factor (Recombinant) kit box label for intravenous use, labeled for Rx only. The packaging describes a plasma derivative containing lyophilized powder and supplies including a pre-filled syringe, vial adapter, butterfly needle, and alcohol swabs. It is manufactured by Octapharma USA Inc and includes storage and usage instructions, ingredients, and regulatory information.*

FDA Label Image

Image Description (Img0014)

NUWIQ 2500 IU Range kit label displaying Antihemophilic Factor (Recombinant) as the active ingredient. For intravenous injection, lyophilized powder form to be reconstituted with a supplied solvent. Manufactured by Octapharma USA Inc in Sweden. Contains lot number, expiration date, and UPC codes visible.*

FDA Label Image

Image Description (Img0015)

NUWIQ 2500 IU Range Antihemophilic Factor (Recombinant) intravenous kit packaging label shows the product name, generic name, dosage strength, and route. It includes contents such as 1 vial with lyophilized powder, 1 pre-filled syringe with water for injection, 1 vial adapter, 1 butterfly needle, and 2 alcohol swabs. The label states it is solvent/detergent treated and nanofiltered. Manufacturer Octapharma USA Inc and distributor information are also present.*

FDA Label Image

Image Description (Img0016)

NUWIQ 3000 IU Range kit label for Antihemophilic Factor (Recombinant) by Octapharma USA Inc. The label details the product as solvent/detergent treated, nanofiltered lyophilized powder for intravenous injection, with instructions for reconstitution and no preservative. It includes regulatory and lot information.*

FDA Label Image

Image Description (Img0017)

NUWIQ 3000 IU Range intravenous kit containing Antihemophilic Factor (Recombinant) by Octapharma USA Inc. The packaging indicates it is solvent/detergent treated and nanofiltered. The kit includes lyophilized powder, pre-filled syringe with water for injection, vial adapter, butterfly needle, and alcohol swabs. Box shows storage instructions and composition details for the reconstituted product.*

FDA Label Image

Image Description (Img0018)

NUWIQ 4000 IU Range kit label for Antihemophilic Factor (Recombinant), a plasma derivative for intravenous use. The label indicates the product is lyophilized powder requiring reconstitution, with no preservatives, treated with solvent/detergent and nanofiltered. Manufactured by Octapharma USA Inc with the U.S. license number and Swedish manufacturing site noted. Includes lot number, expiration date, and NDC code.*

FDA Label Image

Img0019

NUWIQ 4000 IU Range Antiheomphilic Factor (Recombinant) kit packaging label. The label indicates this is a plasma derivative for intravenous use, containing lyophilized powder for injection with supplied solvent. The package lists components including vial, syringe, vial adapter, needle, and alcohol swabs. Labeler is Octapharma USA Inc.*

FDA Label Image

Img0020

Label for 2.5 mL Water for Injection used to reconstitute NUWIQ, an Antihemophilic Factor (Recombinant) kit by Octapharma USA Inc. Instructions include storage between +2°C to 8°C (36°F to 46°F), avoiding freezing, and noting expiry date. Label shows manufacturer and distributor details with lot and expiration date fields.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.